Allison Altersohn

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Bronze - Individuals: litigation

King & Spalding enjoys an outstanding reputation in the pharmaceutical and biotechnology fields. Key reasons for this include the quality, experience and track record of its litigators; but these are by no means the only reasons. The firm also runs a mature, industry-focused prosecution, counselling, diligence and licensing practice, and integrates its IP offering with highly rated practices in FDA regulatory law, product liability and government investigations, among others – all of which makes for a sophisticated wraparound service. Returning to those trial lawyers, Gerald Flattmann, Evan Diamond and Vanessa Yen form an imposing line-up fit to tackle any complex case. The close-knit team has had a lot going on recently: by way of example, it represented Galderma in a trial regarding Sun Pharmaceuticals’ attempt to design around the formulation patents covering Oracea, Galderma’s rosacea treatment, which has chalked up $3 billion in sales since its launch. Sun’s product was found to infringe Galderma’s patents and its invalidity claims were rejected; Sun also withdrew its appeal to the Federal Circuit, keeping the trial win in place and resolving the last pending challenge to the Orange Book listed patents protecting Oracea. As global chair of life sciences patent litigation, Flattmann brings strong leadership to the group. High-technology concerns aren’t left feeling short-changed by King & Spalding’s New York contingent: Allison Altersohn is there with them both in litigation and as a portfolio and licensing strategist. She recently achieved an impressive walkaway win for Delta Airlines, against which Sound View – which has been terrifically successful in monetising its patent portfolios through litigation against other companies – asserted four patents directed to high-performing computing functionality.

Get unlimited access to all IAM content